FBRX – Forte Biosciences Inc
Float Short %
4
Margin Of Safety %
Put/Call OI Ratio
1.88
EPS Next Q Diff
0.24
EPS Last/This Y
7.85
EPS This/Next Y
0.84
Price
19.74
Target Price
63.75
Analyst Recom
1
Performance Q
78.48
Relative Volume
0.53
Beta
3.26
Ticker: FBRX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-11-10 | FBRX | 13.55 | 0.43 | 0.00 | 113 |
| 2025-11-11 | FBRX | 13.91 | 0.43 | 0.00 | 113 |
| 2025-11-12 | FBRX | 14.43 | 0.43 | 999.99 | 113 |
| 2025-11-13 | FBRX | 14.12 | 0.68 | 999.99 | 133 |
| 2025-11-14 | FBRX | 14.42 | 0.82 | 7.50 | 144 |
| 2025-11-17 | FBRX | 14.1 | 1.00 | 0.00 | 150 |
| 2025-11-18 | FBRX | 17.95 | 1.34 | 0.00 | 131 |
| 2025-11-19 | FBRX | 19 | 1.32 | 0.00 | 132 |
| 2025-11-20 | FBRX | 20.45 | 1.21 | 0.67 | 137 |
| 2025-11-21 | FBRX | 18.2 | 1.20 | 3.00 | 141 |
| 2025-11-24 | FBRX | 19.06 | 0.08 | 999.99 | 64 |
| 2025-11-25 | FBRX | 19.79 | 0.93 | 999.99 | 114 |
| 2025-11-26 | FBRX | 18.94 | 1.10 | 0.56 | 124 |
| 2025-12-01 | FBRX | 18.19 | 1.80 | 999.99 | 210 |
| 2025-12-02 | FBRX | 19.03 | 1.88 | 0.00 | 222 |
| 2025-12-03 | FBRX | 18.43 | 1.88 | 0.00 | 222 |
| 2025-12-04 | FBRX | 20.55 | 1.88 | 0.00 | 222 |
| 2025-12-05 | FBRX | 20.29 | 1.88 | 0.00 | 222 |
| 2025-12-08 | FBRX | 19.65 | 1.88 | 0.00 | 222 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-11-10 | FBRX | 13.67 | 76.5 | - | -4.43 |
| 2025-11-11 | FBRX | 14.09 | 76.5 | - | -4.43 |
| 2025-11-12 | FBRX | 14.45 | 76.5 | - | -4.43 |
| 2025-11-13 | FBRX | 13.95 | 76.5 | - | -4.43 |
| 2025-11-14 | FBRX | 14.06 | 76.5 | - | -4.43 |
| 2025-11-17 | FBRX | 14.27 | 76.5 | - | -4.43 |
| 2025-11-18 | FBRX | 17.89 | 76.5 | - | -4.43 |
| 2025-11-19 | FBRX | 18.71 | 76.5 | - | -4.43 |
| 2025-11-20 | FBRX | 20.42 | 76.5 | - | -4.46 |
| 2025-11-21 | FBRX | 18.44 | - | - | -4.46 |
| 2025-11-24 | FBRX | 18.90 | - | - | -4.46 |
| 2025-11-25 | FBRX | 19.99 | - | - | -4.46 |
| 2025-11-26 | FBRX | 18.97 | - | - | -4.46 |
| 2025-12-01 | FBRX | 18.06 | - | - | -4.32 |
| 2025-12-02 | FBRX | 19.09 | - | - | -4.32 |
| 2025-12-03 | FBRX | 18.31 | - | - | -4.32 |
| 2025-12-04 | FBRX | 20.49 | - | - | -4.32 |
| 2025-12-05 | FBRX | 19.93 | - | - | -4.32 |
| 2025-12-08 | FBRX | 19.74 | - | - | -4.32 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-11-10 | FBRX | 0.00 | 44.30 | 2.46 |
| 2025-11-11 | FBRX | 0.00 | 44.30 | 2.46 |
| 2025-11-12 | FBRX | 0.00 | 44.30 | 4.46 |
| 2025-11-13 | FBRX | 0.00 | 44.30 | 4.46 |
| 2025-11-14 | FBRX | 0.00 | 44.30 | 4.46 |
| 2025-11-17 | FBRX | 0.00 | 41.06 | 4.46 |
| 2025-11-18 | FBRX | 0.00 | 41.06 | 4.46 |
| 2025-11-19 | FBRX | 0.00 | 41.06 | 4.42 |
| 2025-11-20 | FBRX | 0.00 | 41.06 | 4.42 |
| 2025-11-21 | FBRX | 0.00 | 41.06 | 4.42 |
| 2025-11-24 | FBRX | 0.00 | 2.41 | 4.42 |
| 2025-11-25 | FBRX | 0.00 | 2.41 | 4.42 |
| 2025-11-26 | FBRX | 0.00 | 2.41 | 4.00 |
| 2025-12-01 | FBRX | 0.00 | 2.39 | 4.00 |
| 2025-12-02 | FBRX | 0.00 | 2.39 | 4.00 |
| 2025-12-03 | FBRX | 0.00 | 2.39 | 4.00 |
| 2025-12-04 | FBRX | 0.00 | 2.39 | 4.00 |
| 2025-12-05 | FBRX | 0.00 | 2.39 | 4.00 |
| 2025-12-08 | FBRX | 0.00 | 2.40 | 4.00 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.99
Avg. EPS Est. Current Quarter
-1.18
Avg. EPS Est. Next Quarter
-0.74
Insider Transactions
Institutional Transactions
2.4
Beta
3.26
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
8
Growth Score
19
Sentiment Score
60
Actual DrawDown %
98.2
Max Drawdown 5-Year %
-99.6
Target Price
63.75
P/E
Forward P/E
PEG
P/S
P/B
2.94
P/Free Cash Flow
EPS
-4.44
Average EPS Est. Cur. Y
-4.32
EPS Next Y. (Est.)
-3.48
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.53
Return on Equity vs Sector %
-88.4
Return on Equity vs Industry %
-73.5
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.12
EBIT Estimation
Forte Biosciences, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 16
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
stock quote shares FBRX – Forte Biosciences Inc Stock Price stock today
news today FBRX – Forte Biosciences Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch FBRX – Forte Biosciences Inc yahoo finance google finance
stock history FBRX – Forte Biosciences Inc invest stock market
stock prices FBRX premarket after hours
ticker FBRX fair value insiders trading